196 related articles for article (PubMed ID: 24135459)
1. Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone-benzimidazole analogs.
Ranganatha VL; Vijay Avin BR; Thirusangu P; Prashanth T; Prabhakar BT; Khanum SA
Life Sci; 2013 Nov; 93(23):904-11. PubMed ID: 24135459
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis.
Vijay Avin BR; Thirusangu P; Lakshmi Ranganatha V; Firdouse A; Prabhakar BT; Khanum SA
Eur J Med Chem; 2014 Mar; 75():211-21. PubMed ID: 24534537
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and anticancer properties of novel benzophenone-conjugated coumarin analogs.
Lakshmi Ranganatha V; Zameer F; Meghashri S; Rekha ND; Girish V; Gurupadaswamy HD; Khanum SA
Arch Pharm (Weinheim); 2013 Dec; 346(12):901-11. PubMed ID: 24170414
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of diamide-coupled benzophenones as potential anticancer agents.
Zabiulla ; Shamanth Neralagundi HG; Bushra Begum A; Prabhakar BT; Khanum SA
Eur J Med Chem; 2016 Jun; 115():342-51. PubMed ID: 27027818
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial antitumor effect of naringenin and curcumin elicit angioinhibitory activities in vivo.
Anand K; Sarkar A; Kumar A; Ambasta RK; Kumar P
Nutr Cancer; 2012; 64(5):714-24. PubMed ID: 22642894
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel morpholine conjugated benzophenone analogues and evaluation of antagonistic role against neoplastic development.
Al-Ghorbani M; Thirusangu P; Gurupadaswamy HD; Vigneshwaran V; Mohammed YH; Prabhakar BT; Khanum SA
Bioorg Chem; 2017 Apr; 71():55-66. PubMed ID: 28139247
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor and proapoptotic effect of novel synthetic benzophenone analogues in Ehrlich ascites tumor cells.
Prabhakar BT; Khanum SA; Jayashree K; Salimath BP; Shashikanth S
Bioorg Med Chem; 2006 Jan; 14(2):435-46. PubMed ID: 16214348
[TBL] [Abstract][Full Text] [Related]
9. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
da Costa PM; da Costa MP; Carvalho AA; Cavalcanti SM; de Oliveira Cardoso MV; de Oliveira Filho GB; de Araújo Viana D; Fechine-Jamacaru FV; Leite AC; de Moraes MO; Pessoa C; Ferreira PM
Chem Biol Interact; 2015 Sep; 239():174-83. PubMed ID: 26134001
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of novel benzophenone-thiazole derivatives as potent VEGF-A inhibitors.
Prashanth T; Thirusangu P; Vijay Avin BR; Lakshmi Ranganatha V; Prabhakar BT; Khanum SA
Eur J Med Chem; 2014 Nov; 87():274-83. PubMed ID: 25261825
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1alpha and down regulation of VEGF of in-vivo.
Prabhakar BT; Khanum SA; Shashikanth S; Salimath BP
Invest New Drugs; 2006 Nov; 24(6):471-8. PubMed ID: 16598437
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel N
Guo L; Ma Q; Chen W; Fan W; Zhang J; Dai B
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):375-387. PubMed ID: 30734606
[TBL] [Abstract][Full Text] [Related]
13. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of tumor growth and tumor angiogenesis of mouse ehrlich ascites tumor in vivo.
Kumar CS; Chandru H; Sharada AC; Thimmegowda NR; Prasad SB; Kumar MK; Rangappa KS
Med Chem; 2008 Sep; 4(5):466-72. PubMed ID: 18782043
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and docking studies of new 2-furylbenzimidazoles as anti-angiogenic agents: part II.
Temirak A; Shaker YM; Ragab FA; Ali MM; Soliman SM; Mortier J; Wolber G; Ali HI; El Diwani HI
Arch Pharm (Weinheim); 2014 Apr; 347(4):291-304. PubMed ID: 24497234
[TBL] [Abstract][Full Text] [Related]
16. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
18. A novel anti-tumor agent, Ln(III) 2-thioacetate benzothiazole induces anti-angiogenic effect and cell death in cancer cell lines.
Hussein BH; Azab HA; el-Azab MF; el-Falouji AI
Eur J Med Chem; 2012 May; 51():99-109. PubMed ID: 22424613
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
20. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
